Hantech Bio-Technology Co., Ltd. manufactures and sells science-based health products, eco-friendly pouch & dietary supplements. The company was founded in 2007 and is headquartered in Yuanlin, Taiwan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1294 is 89.0 TWD — it has increased by 9.92% in the past 24 hours. Watch HANTECH BIO-TECHNO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange HANTECH BIO-TECHNO stocks are traded under the ticker 1294.
1294 stock has risen by 2.94% compared to the previous week, the month change is a −3.31% fall, over the last year HANTECH BIO-TECHNO has showed a 12.33% increase.
We've gathered analysts' opinions on HANTECH BIO-TECHNO future price: according to them, 1294 price has a max estimate of 107.00 TWD and a min estimate of 107.00 TWD. Watch 1294 chart and read a more detailed HANTECH BIO-TECHNO stock forecast: see what analysts think of HANTECH BIO-TECHNO and suggest that you do with its stocks.
1294 reached its all-time high on Apr 9, 2024 with the price of 231.5 TWD, and its all-time low was 20.1 TWD and was reached on Sep 30, 2022. View more price dynamics on 1294 chart. See other stocks reaching their highest and lowest prices.
1294 stock is 4.91% volatile and has beta coefficient of −0.21. Track HANTECH BIO-TECHNO stock price on the chart and check out the list of the most volatile stocks — is HANTECH BIO-TECHNO there?
HANTECH BIO-TECHNO is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
1294 earnings for the last quarter are 1.58 TWD per share, whereas the estimation was 1.58 TWD resulting in a 0.00% surprise. The estimated earnings for the next quarter are 1.66 TWD per share. See more details about HANTECH BIO-TECHNO earnings.
HANTECH BIO-TECHNO revenue for the last quarter amounts to 198.00 M TWD, despite the estimated figure of 198.00 M TWD. In the next quarter, revenue is expected to reach 210.00 M TWD.
1294 net income for the last quarter is 43.00 M TWD, while the quarter before that showed 46.22 M TWD of net income which accounts for −6.97% change. Track more HANTECH BIO-TECHNO financial stats to get the full picture.
Yes, 1294 dividends are paid annually. The last dividend per share was 1.00 TWD. As of today, Dividend Yield (TTM)% is 0.97%. Tracking HANTECH BIO-TECHNO dividends might help you take more informed decisions.
HANTECH BIO-TECHNO dividend yield was 0.96% in 2023, and payout ratio reached 13.11%. The year before the numbers were 2.03% and 40.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2024, the company has 154.00 employees. See our rating of the largest employees — is HANTECH BIO-TECHNO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HANTECH BIO-TECHNO EBITDA is 256.88 M TWD, and current EBITDA margin is 33.06%. See more stats in HANTECH BIO-TECHNO financial statements.
Like other stocks, 1294 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HANTECH BIO-TECHNO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HANTECH BIO-TECHNO technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HANTECH BIO-TECHNO stock shows the sell signal. See more of HANTECH BIO-TECHNO technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.